To understand the key launch trends in 2024, GlobalData reviewed a sample of innovative drugs that were both approved and ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

CHARLESTON — West Virginia Attorney General JB McCuskey joined a 37-state and territory bipartisan coalition urging the Food and Drug Administration to take swift action against bad actors who are ...

CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL, Feb. 20, 202 ...

Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...